Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Obstructive Sleep Apnea
NCT07570953Phase 3Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol in obstructive sleep apnea (OSA), sponsored by Mayo Clinic. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dronabinol
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT07570953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07570953.